VW Needs `Titanic' Effort to Conquer Emissions, Trade Issues
(Bloomberg) -- Volkswagen AG warned that it will take a huge effort to meet delivery targets this year, as the world's largest automaker battles trade tensions and stricter emissions rules while preparing to amp up its digital investments.
Tougher pollution-testing procedures, aimed at preventing a repeat of Volkswagen's cheating scandal, will take effect next month and lead to production slowdowns, the German automaker said Wednesday. The German manufacturer is also bracing for higher tariffs around the globe, which could particularly hit Audi and Porsche, the group's main profit earners.
“Protectionist tendencies are escalating worldwide,” Chief Executive Officer Herbert Diess said in a speech on Wednesday.
Meeting delivery goals while avoiding deep discounts this year will be a “titanic task,” said Diess, who recently completed his first 100 days in office.
Looking ahead, Diess is trying to ready the automaker for coming challenges, from electrification to self-driving cars to new businesses like car-sharing. The company needs a “massive expansion” in software and in its digital investments, including partnerships and acquisitions, as it faces new competition from China and the U.S. West Coast, he said. “Those are the challenges,” Diess said in a Bloomberg TV interview.
Click here to read about VW's battery partnership with QuantumScape
Volkswagen shares fell after the company, based in Wolfsburg, Germany, said it wouldn't be able to repeat the 23 percent surge in profit it reported for the second quarter. The challenges range from economic volatility, increasing competition and the costs of the ongoing diesel scandal, to new, time-consuming exhaust testing in the EU, Volkswagen said in a statement Wednesday.
The cost of implementing so-called WLTP tests may reach 1 billion euros ($1.17 billion), Chief Financial Officer Frank Witter said on a call. The carmaker churned out more vehicles ahead of the rules change, as production jumped 13.5 percent in the second quarter, twice the growth rate of deliveries. Volkswagen said earlier this year that the company may experience inventory build-up ahead of the Sept. 1 introduction of the Worldwide Harmonized Light-Duty Test Procedure.
Diess is grappling with political challenges alongside an internal overhaul in the aftermath of the three-year-old diesel crisis, which continues to burden the industrial giant. In the second quarter, the company took 1.64 billion euros ($1.92 billion) in charges, mainly for a fine from German authorities, raising the total damages to about 27.4 billion euros. Rupert Stadler, the now-suspended head of the Audi luxury unit, was arrested in June by Munich prosecutors and remains in custody.
Volkswagen shares fell as much as 4.5 percent, and were down 3.3 percent at 147.28 euros at 4:26 p.m. in Frankfurt trading, taking the decline for the year to 12 percent.
While Volkswagen is investing in technology, Diess said he doesn't see a need for sweeping auto-industry consolidation. A recent joint venture with Ford in light commercial vehicles will allow the companies to pool development costs for electrification, he said, taking the edge off of one-time expenditures in areas like battery-powered and self-driving cars that are hitting at once.
“We cannot rest on our laurels because great challenges lie ahead of us in the coming quarters,” Diess said. “Growing protectionism also poses major challenges for the globally integrated automotive industry.”
Earnings Highlights |
|
|
|
|
|
|
|
To contact the reporter on this story: Christoph Rauwald in Frankfurt at crauwald@bloomberg.net
To contact the editors responsible for this story: Anthony Palazzo at apalazzo@bloomberg.net, Chris Reiter
©2018 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.